Cellid Surges on COVID Fears; VUNO Plunges on Rights Offering[K-Bio Pulse]

South Korean biotech and healthcare stocks diverged sharply on Aug. 31. Cellid Co., Ltd. surged 27% on renewed COVID-19 concerns, Onconic Therapeutics Inc. jumped 22% on a U.S. patent allowance for N...